(Q28300792)

https://api.crossref.org/works/10.1080/10245330500329094

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10245330500329094

Autoimmune lymphoproliferative syndrome with somatic Fas mutations

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10245330500329094

Autoimmune lymphoproliferative syndrome

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10245330500329094

Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS)

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10245330500329094

Development of lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10245330500329094

Reversion of autoimmune lymphoproliferative syndrome with an antimalarial drug: preliminary results of a clinical cohort study and molecular observations

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10245330500329094

Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10245330500329094

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome

21 April 2017

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

Paths to understanding the genetic basis of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

The molecular regulation of lymphocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

Apoptosis in hematological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

SPOTS: signaling protein oligomeric transduction structures are early mediators of death receptor-induced apoptosis at the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

Autoimmune lymphoproliferative syndrome type III: an indefinite disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

Pathological findings in human autoimmune lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

RBC autoantibodies in autoimmune lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

Report of a factor VIII inhibitor in a patient with autoimmune lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

Autoimmune lymphoproliferative syndrome, a disorder of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

Defining CD95 as a tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

The role of PET imaging in lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094

Dyserythropoiesis associated with a Fas-deficient condition in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330500329094